Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

411 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Identifying obstacles hindering the conduct of academic-sponsored trials for drug repurposing on rare-diseases: an analysis of six use cases.
Del Álamo M, Bührer C, Fisher D, Griese M, Lingor P, Palladini G, Sireau N, Hivert V, Sangiorgi L, Guillot F, Halftermeyer J, Soucková L, Nosková K, Demlová R. Del Álamo M, et al. Among authors: palladini g. Trials. 2022 Sep 15;23(1):783. doi: 10.1186/s13063-022-06713-y. Trials. 2022. PMID: 36109818 Free PMC article.
Amyloidosis: is a cure possible?
Merlini G, Palladini G. Merlini G, et al. Among authors: palladini g. Ann Oncol. 2008 Jun;19 Suppl 4:iv63-6. doi: 10.1093/annonc/mdn200. Ann Oncol. 2008. PMID: 18519408 Free article. Review. No abstract available.
Two-hit strategy for treating AL amyloidosis?
Merlini G, Palladini G. Merlini G, et al. Among authors: palladini g. Blood. 2021 Dec 23;138(25):2596-2598. doi: 10.1182/blood.2021013817. Blood. 2021. PMID: 34940822 Free article. No abstract available.
Systemic amyloidoses: what an internist should know.
Palladini G, Merlini G. Palladini G, et al. Eur J Intern Med. 2013 Dec;24(8):729-39. doi: 10.1016/j.ejim.2013.10.007. Epub 2013 Nov 18. Eur J Intern Med. 2013. PMID: 24262289 Review.
Rationale, application and clinical qualification for NT-proBNP as a surrogate end point in pivotal clinical trials in patients with AL amyloidosis.
Merlini G, Lousada I, Ando Y, Dispenzieri A, Gertz MA, Grogan M, Maurer MS, Sanchorawala V, Wechalekar A, Palladini G, Comenzo RL. Merlini G, et al. Among authors: palladini g. Leukemia. 2016 Oct;30(10):1979-1986. doi: 10.1038/leu.2016.191. Epub 2016 Jul 15. Leukemia. 2016. PMID: 27416985 Free PMC article. Review.
411 results